Sunil Rajasekar insider trades: Healthequity (HQY) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Sunil reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | HQY | ↑ Buy | 131 | $91.16 | $12K | Direct | Oct 19, 2026 (4d) |
| Aug 24, 2026 | HQY | ↓ Sell | 131 | $101.60 | $13K | Direct | Oct 19, 2026 (56d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other HQY insiders
Open-market trades in the last 12 months
About Sunil Rajasekar's insider trades
Sunil Rajasekar is EVP Chief Prod & Strat Officer at Healthequity (HQY). Since Aug 24, 2026, Sunil has reported 1 open-market purchase worth $12K and 1 sale worth $13K on SEC Form 4. In the last 12 months: 1 buy ($12K) and 1 sale ($13K).
Their filings also include grants and awards (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HQY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.